Acura Pharmaceuticals Profile

USD 0.02  5.58%
0.34Last Month High 0.44 
0.34Trading Day  High 0.38 

Acquisition by Albert Brzeczko of 28000 shares of Acura Pharmaceuticals subject to Rule 16b-3

Acura Pharmaceuticals Inc insider trading alert for grant of restricted stock units by Albert Brzeczko, VP Technical Affairs - APT, on December 11, 2017. This event was filed by Acura Pharmaceuticals Inc with SEC on 2017-12-11. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Acura Pharmaceuticals Summary

Acura Pharmaceuticals Inc (ACUR) is traded on OTC Market in USA. It is located in ILLINOIS, U.S.A and employs 15 people. Acura Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 7.07 M. Acura Pharmaceuticals Inc has 20.8 M outstanding shares of which 89.85 K shares are presently shorted by private and institutional investors with about 0.73 trading days to cover. ACURA PHARMACEUTI currently holds about 4.79 M in cash with (1.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check Acura Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Essex Woodlands Health Ventures IncCommon Shares2 M880 K
Essex Woodlands Health Ventures IncCommon Shares2 M1.1 M
Simplex Trading LlcPut Options86.037 K
Simplex Trading LlcCall Options69.01000
View Acura Pharmaceuticals Diagnostics

Selected Acura Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Acura Pharmaceuticals Against Markets

Current Ratings  

Acura Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 94% 
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes solutions to address medication abuse and misuse. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAcura Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address616 N. North Court, Suite 120, Palatine, IL 60067, United States
ExchangeOTC Market
CIK Number00786947.0
IndustryPharmaceutical Products
Contact Number847 705 7709
CurrencyUSD - US Dollar

Current Sentiment - ACUR

Acura Pharmaceuticals Inc Investor Sentiment
Most of Macroaxis users are presently bullish on Acura Pharmaceuticals Inc. What is your sentiment towards investing in Acura Pharmaceuticals Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
ACURSkip  Hide


Acura Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
6.0Strong Buy1Odds
Acura Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Acura Pharmaceuticals Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas